The European Journal of Internal Medicine is a leading academic publication dedicated to advancing the field of internal medicine, published by ELSEVIER from the Netherlands. With an impressive impact factor and a Q1 ranking in the Internal Medicine category, this journal stands out as a vital resource for researchers, healthcare professionals, and students alike. Spanning over three decades of converged publications from 1989 to 2024, it features high-quality peer-reviewed articles that cover a wide array of topics pertinent to clinical practice and medical research. Recognized for its contribution to the field, it occupies the notable 22nd position among 167 in Scopus rankings, reflecting its influential role in shaping contemporary medical discourse. The European Journal of Internal Medicine is not only a hub for innovative findings but also serves as a platform for interdisciplinary collaboration, offering valuable insights that foster advancements in patient care and treatment methodologies.

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

The American Journal of Physiology - Renal Physiology (ISSN: 1931-857X; E-ISSN: 1522-1466), published by the esteemed American Physiological Society, serves as a premier platform for disseminating significant research in the field of renal physiology. This journal, recognized for its high impact factor and classified in the Q1 category for both Physiology and Urology as of 2023, showcases innovative studies, reviews, and critical commentaries that deepen our understanding of kidney function and its implications on overall health. With coverage extending from 1977 to 2024, the journal is crucial for researchers, clinicians, and students who are eager to explore the latest findings and advancements in renal research. Although it does not provide Open Access options, the journal's commitment to rigorous peer review ensures that only the highest quality of scientific inquiry reaches its audience, solidifying its reputation as a vital resource in the field.

TERAPEVTICHESKII ARKHIV, published by CJSC CONSILIUM MEDICUM, is a distinguished open-access journal that has been pivotal in the fields of Endocrinology, Family Practice, History, and Internal Medicine since its inception in 1949. Recognized in 2023 with quartile rankings of Q3 in Family Practice and notable placements in other categories, the journal aims to disseminate high-quality research, innovative treatment methods, and comprehensive reviews that advance the understanding of medical practices and historical contexts within these disciplines. With its commitment to accessibility, as demonstrated by its open-access policy initiated in 2018, TERAPEVTICHESKII ARKHIV serves as an invaluable resource for researchers, healthcare professionals, and students looking to stay abreast of cutting-edge advances and historical perspectives in medicine, especially within the Russian Federation. The journal’s focus on interdisciplinary approaches encourages a rich dialogue across various medical fields, underlining its significance in fostering a well-rounded academic community.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

The International Journal of Nephrology and Renovascular Disease is a prestigious peer-reviewed journal dedicated to advancing the field of nephrology and related renal research. Published by DOVE MEDICAL PRESS LTD, this open access journal has been a vital resource for the nephrology community since its inception in 2008. With a focus on innovative studies and emerging trends, the journal has established itself in the scholarly landscape, achieving an impressive Q2 ranking within the nephrology category according to the 2023 Scopus metrics, and positioning itself at rank #33 out of 81 journals in the field. The journal aims to provide a platform for both established researchers and emerging scholars to share their findings and insights, significantly contributing to improving patient outcomes and enhancing the understanding of renal health. As it continuously seeks to publish high-quality research that reflects the latest developments in the discipline, the International Journal of Nephrology and Renovascular Disease serves as an indispensable tool for anyone involved in nephrology research, clinical practice, and education.

CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.

Arterial Hypertension is a dedicated Open Access journal published by VIA MEDICA, with the ISSN 2449-6170 and E-ISSN 2449-6162, focusing on the multidisciplinary field of cardiology, endocrinology, and internal medicine. Established in Poland, this journal has been providing researchers and healthcare professionals with accessible, high-quality content since its inception in 1999. With a commitment to advancing knowledge in the management and treatment of arterial hypertension, it publishes significant research findings, clinical trials, and reviews that contribute to improved health outcomes. Though classified in Q4 across various relevant categories, the continuous improvement in its content ensures its relevance in an evolving medical landscape. Designed to facilitate collaboration and innovation, Arterial Hypertension serves as a crucial resource for anyone invested in cardiovascular health, encouraging open dialogue and dissemination of vital research within the scientific community.

JOURNAL OF CLINICAL INVESTIGATION is a premier scholarly journal published by the American Society for Clinical Investigation, dedicated to advancing the field of clinical research and medicine since its inception in 1945. With an impressive impact factor and ranked Q1 in the field of Medicine (miscellaneous), it stands out as a leading source of high-quality research, reflecting its exceptional position in Scopus ranking as #13 out of 636 in General Medicine, placing it in the 98th percentile. The journal focuses on groundbreaking studies that explore the underlying mechanisms of human disease, facilitating a deeper understanding that drives clinical practice and innovation. Although it is not an open-access journal, the insights and findings published in this esteemed journal are essential reading for researchers, healthcare professionals, and students aspiring to contribute to the dynamic landscape of clinical investigation. Published in the United States, it continues to shape the dialogue and advancement within the medical community through its rigorous peer-review process and commitment to excellence.

Kidney International Reports, published by ELSEVIER SCIENCE INC, stands as a premier open-access journal in the realm of nephrology, having established itself since its inception in 2016. This scholarly platform, with an ISSN of 2468-0249, is dedicated to presenting high-quality research and critical reviews that advance our understanding of kidney health and disease. With a remarkable Q1 ranking in nephrology and a notable position within the top 10 of Scopus rankings for this specialty, the journal is a pivotal resource for researchers, healthcare professionals, and students alike. Featuring a broad scope of topics from clinical nephrology to innovative treatment strategies, Kidney International Reports ensures accessibility to the latest findings through its open access model, making it instrumental in promoting knowledge sharing and collaboration across the global nephrology community. The journal's commitment to excellence not only enhances the visibility of research but also fosters the development of effective treatments and therapies for kidney diseases.